SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma (SIRCCA)

Study Title

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma (SIRCCA)

NCT Number

NCT02807181

IDE Number

G160128

CMS Approval Date

2017-10-26

Clinical Trial Link

https://clinicaltrials.gov/ct2/show/NCT02807181

Category

B

Website

https://clinicaltrials.gov/ct2/show/NCT02807181